CompletedHealthcare23 April 2026

Servier to acquire Day One Biopharmaceuticals, Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Servier
Target
Day One Biopharmaceuticals, Inc.
Deal value
USD 2,500,000,000
Announced
23 April 2026
Status
Completed
Sector
Healthcare
Country
United States
Consideration
cash
What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update
  1. CompletedClosed

    Servier completes acquisition of Day One Biopharmaceuticals, Inc.

    INTRODUCTORY NOTE As previously reported in the Current Report on Form 8-K filed on March 6, 2026, with the U.S. Securities and Exchange Commission (the “ SEC ”), on March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company (“ Parent ”), Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Purchaser ”), Day One Biopharmaceuticals, Inc., a D

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Servier

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive